Research Topics
| Marianne Ulcickas YoodSummaryAffiliation: Josephine Ford Cancer Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Cardiovascular outcomes in women with advanced breast cancer exposed to chemotherapyMarianne Ulcickas Yood
EpiSource, Newton, MA, USA
Pharmacoepidemiol Drug Saf 21:818-27. 2012..To quantify incidence of cardiovascular outcomes in patients with advanced breast cancer receiving cardiotoxic and non-cardiotoxic chemotherapy...- Adherence to treatment with second-line therapies, dasatinib and nilotinib, in patients with chronic myeloid leukemiaMarianne Ulcickas Yood
EpiSource, LLC, Newton, MA, USA
Curr Med Res Opin 28:213-9. 2012..This study evaluates real-world adherence in patients diagnosed with CML receiving dasatinib or nilotinib as second-line therapy... 
The impact of NSAID or COX-2 inhibitor use on the initiation of antihypertensive therapyMarianne Ulcickas Yood
Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT, USA
Pharmacoepidemiol Drug Saf 15:852-60. 2006..The objective of this study was to quantify the associations between NSAIDs and COX-2 inhibitors and risk for initiating antihypertensive therapy...- Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infectionMarianne Ulcickas Yood
Josephine Ford Cancer Center, Henry Ford Health System, Detroit, MI, USA
Hepatology 46:107-12. 2007..16-6.75), after controlling for age, race, sex, income, Charlson comorbidity index, study site, and HCV infection. CONCLUSION: chronic HBV-infected patients were nearly 3 times more likely to develop NHL than comparison patients... - Using prescription claims data for drugs available over-the-counter (OTC)Marianne Ulcickas Yood
Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT, USA
Pharmacoepidemiol Drug Saf 16:961-8. 2007..The purpose of this study is to quantify the effect of misclassification of OTC use in research that uses prescription claims data as the sole source of exposure information... - Incidence of hepatocellular carcinoma among individuals with hepatitis B virus infection identified using an automated data algorithmM Ulcickas Yood
Josephine Ford Cancer Center, Henry Ford Health System, Detroit, MI, USA
J Viral Hepat 15:28-36. 2008..8, 95% CI: 25.9-55.1). The magnitude of the relative increase in HCC risk seen using different criteria used to define HBV infection indicate that these automated data algorithms can identify patients with chronic HBV infection... - The incidence of diabetes in atypical antipsychotic users differs according to agent--results from a multisite epidemiologic studyMarianne Ulcickas Yood
EpiSource, Hamden, CT, USA
Pharmacoepidemiol Drug Saf 18:791-9. 2009.... - Epidemiologic study of aripiprazole use and the incidence of suicide eventsMarianne Ulcickas Yood
EpiSource, Newton, MA, USA
Pharmacoepidemiol Drug Saf 19:1124-30. 2010..To fulfill a postmarketing request, our objective was to determine suicide event (attempted or completed) incidence in patients with schizophrenia or bipolar disorder, prescribed aripiprazole... 
Association between second-generation antipsychotics and newly diagnosed treated diabetes mellitus: does the effect differ by dose?Marianne Ulcickas Yood
EpiSource, LLC, Newton, MA, USA
BMC Psychiatry 11:197. 2011..The benefits of some second-generation antipsychotics (SGAs) must be weighed against the increased risk for diabetes mellitus. This study examines whether the association between SGAs and diabetes differs by dose...- Racial differences in reaching target low-density lipoprotein goal among individuals treated with prescription statin therapyMarianne Ulcickas Yood
EpiSource, Hamden, CT, USA
Am Heart J 152:777-84. 2006..No population-based studies have examined the effect of race on achieving target low-density lipoprotein (LDL) goals among treated individuals... - Time to pharmacotherapy change in response to elevated HbA1c test resultsMarianne Ulcickas Yood
EpiSource, 275 Blue Trail, Hamden, CT 06518, USA
Curr Med Res Opin 22:1567-74. 2006..This study describes the clinical management of type 2 diabetes among a cohort of patients receiving oral antidiabetic monotherapy... - An observational study examining the impact of capecitabine on warfarin antithrombotic activity and bleeding complicationsMarianne Ulcickas Yood
Josephine Ford Cancer Center, Henry Ford Health System, Detroit, MI, USA
Curr Med Res Opin 22:307-14. 2006.... - What do medical records tell us about potentially harmful co-prescribing?Jennifer Elston Lafata
Center for Health Services Research, Henrry Ford Health System, Detroit, USA
Jt Comm J Qual Patient Saf 33:395-400. 2007..Previous efforts document drug-drug interactions in ambulatory care. Yet little is known about medical record documentation or clinical management when interacting medications are received... - Potential drug-drug interactions in the outpatient settingJennifer Elston Lafata
Henry Ford Health System, Detroit, Michigan 48202, Channing Laboratory, Brigham and Women s Hospital, and Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA
Med Care 44:534-41. 2006..Although medication safety research has tended to focus on inpatients, the safety of drug use among outpatients is also a concern... - Potential misinterpretations caused by collapsing upper categories of comorbidity indices: An illustration from a cohort of older breast cancer survivorsThomas P Ahern
Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA
Clin Epidemiol 1:93-100. 2009..Low subject prevalence in the highest strata of a comorbidity index often prompts combination of upper categories into a single stratum ('collapsing')... - Mortality impact of less-than-standard therapy in older breast cancer patientsMarianne Ulcickas Yood
Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT, USA
J Am Coll Surg 206:66-75. 2008.... - Routine surveillance care after cancer treatment with curative intentJennifer Elston Lafata
Center for Health Services Research, Henry Ford Health System, Detroit, Michigan 48202, USA
Med Care 43:592-9. 2005..Many consensus guidelines recommend routine surveillance to detect recurrent disease among cancer survivors. We compare surveillance care receipt to guideline recommendations... - Prescription drug use in pregnancySusan E Andrade
Meyers Primary Care Institute Fallon Healthcare System and University of Massachusetts Medical School, 630 Plantation Street, Worcester, MA, USA
Am J Obstet Gynecol 191:398-407. 2004..The purpose of this study was to provide information on the prevalence of the use of prescription drugs among pregnant women in the United States... - The coprescription of contraindicated drugs with statins: continuing potential for increased risk of adverse eventsPaul Stang
Galt Associates, Inc, Blue Bell, PA 19422, USA
Am J Ther 14:30-40. 2007..Coprescribing of medications not compatible with statins occurs frequently. The extent of coprescribing indicates the need for additional intervention to assure that the risk of untoward effects is mitigated... - Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profileFelix M Arellano
Risk Management Resources, LLC Bridgewater, NJ 08807, USA
Pharmacoepidemiol Drug Saf 15:861-72. 2006..COX-2 and NSAIDS differ in their gastrointestinal (GI) and cardiovascular (CV) toxicity from pharmacological, clinical and epidemiologic point of views... - Reason for late-stage breast cancer: absence of screening or detection, or breakdown in follow-up?Stephen H Taplin
Group Health Cooperative, Seattle, WA, USA
J Natl Cancer Inst 96:1518-27. 2004..However, despite high national mammography screening rates, late-stage breast cancers still occur, possibly because of failures in screening implementation... - Administrative data used to identify patients with irritable bowel syndromeSarah L Goff
Meyers Primary Care Institute, University of Massachusetts Medical School, Fallon Clinic Foundation and Fallon Community Health Plan, 630 Plantation Street, Worcester, MA 01605, USA
J Clin Epidemiol 61:617-21. 2008..To assess the usefulness of health plan administrative data for identifying patients with irritable bowel syndrome (IBS)... - Breast cancer treatment of older women in integrated health care settingsShelley M Enger
Department of Research and Evaluation, Kaiser Permanente Medical Care Program, Pasadena, CA, USA
J Clin Oncol 24:4377-83. 2006..Information regarding treatment effectiveness in this age group and tools that allow physicians and patients to estimate the benefits versus the risks of therapies, taking into account age and comorbidity burden, are critically needed... - Use of prescription medications with a potential for fetal harm among pregnant womenSusan E Andrade
Meyers Primary Care Institute University of Massachusetts Medical School, the Fallon Foundation, and Fallon Community Health Plan, Worcester, MA 01605, USA
Pharmacoepidemiol Drug Saf 15:546-54. 2006..To estimate the prevalence of use of prescription drugs with a potential for fetal harm among pregnant women in the United States... - Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancerCynthia Owusu
Division of Hematology Oncology, Case Western Reserve University, University Hospitals Health System Ireland Cancer Center BHC 5055, 11100 Euclid Ave, Cleveland, OH 44106 5055, USA
J Clin Oncol 26:549-55. 2008..However, information on tamoxifen discontinuation is scanty. We sought to identify predictors of tamoxifen discontinuation among older women with breast cancer... - Under utilization of surveillance mammography among older breast cancer survivorsTerry S Field
Meyers Primary Care Institute, Worcester, MA 01605, USA
J Gen Intern Med 23:158-63. 2008..Annual surveillance mammography is recommended for follow-up of women with a history of breast cancer. We examined surveillance mammography among breast cancer survivors who were enrolled in integrated healthcare systems... - Use of anti-inflammatory drugs and lower esophageal sphincter-relaxing drugs and risk of esophageal and gastric cancersJoan Fortuny
Epidemiology and Biostatistics Department, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Clin Gastroenterol Hepatol 5:1154-1159.e3. 2007..We investigated whether use of LES-relaxing drugs was related to an increased risk of esophageal and gastric cardia adenocarcinoma, and whether use of NSAIDs was related to a reduced risk of esophageal and gastric cancers... - Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators aloneDouglas W Mapel
Lovelace Clinic Foundation, Albuquerque, NM 87106, USA
COPD 4:127-34. 2007..The treatment benefit is reproducible and is robust to application of a number of different analysis techniques designed to adjust for differences in confounding variables and for bias by indication... - Use of guideline recommended follow-up care in cancer survivors: routine or diagnostic indications?Gregory S Cooper
Division of Gastroenterology and Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio 44106 5066, USA
Med Care 44:590-4. 2006..After potentially curative cancer treatment, patients may receive procedures for routine monitoring for recurrence or for evaluation of symptoms or signs... - Using probabilistic corrections to account for abstractor agreement in medical record reviewsTimothy L Lash
Boston University School of Public Health, Boston, MA 02118, USA
Am J Epidemiol 165:1454-61. 2007..While many investigators use reliability data only as a metric for data quality, a more thorough approach can also quantitatively depict the uncertainty in the observed associations... - Treatment and referral patterns for colorectal cancerSusan A Oliveria
Galt Associates, Inc, Sterling, Virginia, USA
Med Care 42:901-6. 2004..National guidelines recommend adjuvant chemotherapy for colorectal cancer stages III, and IV; however, it has been shown that only 45-55% of these patients receive chemotherapy...